Literature DB >> 31233726

Space-time analysis of the incidence of human visceral leishmaniasis (VL) and prevalence of canine VL in a municipality of southeastern Brazil: Identification of priority areas for surveillance and control.

Rubiane Mendes Faria de Arruda1, Diogo Tavares Cardoso2, Rafael Gonçalves Teixeira-Neto3, David Soeiro Barbosa4, Ruan Krubniki Ferraz5, Maria Helena Franco Morais6, Vinícius Silva Belo7, Eduardo Sérgio da Silva8.   

Abstract

Human and canine visceral leishmaniasis (HVL and CVL, respectively) represent serious public health issues in Brazil. The surveillance and control measures currently employed have had limited effect in impeding the territorial expansion of the disease and in reducing the number of cases. We have investigated the space-time distribution of HVL incidence rates and CVL prevalence in the coverage areas of the 148 primary healthcare units in Belo Horizonte (MG, Brazil) during a 6-year period in order to identify those that should be prioritized for disease control actions. Data were smoothed using the empirical Bayes method and analyzed by space-time scanning and application of univariate global Moran's I index and local indicators of spatial association (LISA) statistics to identify spatial autocorrelations. Point data of CVL were analyzed using the Kernel method. Bivariate global Moran's I and LISA techniques were employed to identify spatial correlations between HVL and CVL. Based on our results, we were able to formulate two proposals for establishing the prioritization of coverage areas, namely: (i) classification of maximum priority areas as identified by bivariate LISA for HVL and CVL, and (ii) combination of maximum priority areas with high priority areas as identified by univariate LISA for HVL. According to our proposals, 27 coverage areas in Belo Horizonte were categorized as maximum priority and a further 13 were classified as high priority. Our proposals, which are based on practical, feasible and inexpensive statistical tools, will contribute to a better understanding of VL distribution in urban settings and improving the efficiency of governmental control programs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epidemiology; Risk assessment; Spatial analysis; Visceral leishmaniasis; Zoonoses

Mesh:

Year:  2019        PMID: 31233726     DOI: 10.1016/j.actatropica.2019.105052

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.

Authors:  Fabiana Rodrigues de Santana; Danielle Aparecida Marino da Silva; Simone Katz; Cristina Mary Orikaza; Katia Cristina Oliveira; Clara Lúcia Barbiéri
Journal:  Parasitol Res       Date:  2022-08-23       Impact factor: 2.383

2.  Cases and distribution of visceral leishmaniasis in western São Paulo: A neglected disease in this region of Brazil.

Authors:  Regiane Soares Santana; Karina Briguenti Souza; Fernanda Lussari; Elivelton Silva Fonseca; Cristiane Oliveira Andrade; Marcia Mitiko Kaihara Meidas; Lourdes Aparecida Zampieri D'Andrea; Francisco Assis Silva; Edilson Ferreira Flores; Ivete Rocha Anjolete; Luiz Euribel Prestes-Carneiro
Journal:  PLoS Negl Trop Dis       Date:  2021-06-15

3.  Space-time risk cluster of visceral leishmaniasis in Brazilian endemic region with high social vulnerability: An ecological time series study.

Authors:  Caique J N Ribeiro; Allan D Dos Santos; Shirley V M A Lima; Eliete R da Silva; Bianca V S Ribeiro; Andrezza M Duque; Marcus V S Peixoto; Priscila L Dos Santos; Iris M de Oliveira; Michael W Lipscomb; Karina C G M de Araújo; Tatiana R de Moura
Journal:  PLoS Negl Trop Dis       Date:  2021-01-19

4.  Passive case detection for canine visceral leishmaniasis control in urban Brazil: Determinants of population uptake.

Authors:  João Gabriel G Luz; Amanda G de Carvalho; João Victor L Dias; Luis Claudio L Marciano; Sake J de Vlas; Cor Jesus F Fontes; Luc E Coffeng
Journal:  PLoS Negl Trop Dis       Date:  2021-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.